Attached files

file filename
EX-32.1 - EX-32.1 - 10x Genomics, Inc.txg-20200630xex321.htm
EX-31.2 - EX-31.2 - 10x Genomics, Inc.txg-20200630xex312.htm
EX-31.1 - EX-31.1 - 10x Genomics, Inc.txg-20200630xex311.htm
EX-10.7 - EX-10.7 - 10x Genomics, Inc.ex107.htm
EX-10.6 - EX-10.6 - 10x Genomics, Inc.txg-ex106.htm
10-Q - 10-Q - 10x Genomics, Inc.txg-20200630.htm

Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Justin McAnear, the Chief Financial Officer of 10x Genomics, Inc. (the “Company”), hereby certify, that, to my knowledge:
1.The Quarterly Report on Form 10-Q for the period ended June 30, 2020 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 12, 2020By:
/s/ Justin McAnear
Justin McAnear
Chief Financial Officer
(Principal Financial and Accounting Officer)